Preliminary studies suggest conolidine may perhaps inhibit distinct ion channels, lessening neuronal excitability and limiting discomfort indicators. This mechanism is particularly related in neuropathic soreness, where by abnormal signaling causes persistent pain. On top of that, conolidine seems to impact G protein-coupled receptor (GPCR) pathway